Mitochondria as Targets for Endothelial Protection in COVID-19
Main Authors: | Boris V. Chernyak, Ekaterina N. Popova, Ludmila A. Zinovkina, Konstantin G. Lyamzaev, Roman A. Zinovkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2020.606170/full |
Similar Items
-
Prospects for Drugs Based on the Mitochondria-Targeting Antioxidant SkQ1 in Treatment of Wounds with Impaired Healing
by: R. A. Zinovkin, et al.
Published: (2018-05-01) -
Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor α
by: Ludmila A. Zinovkina, et al.
Published: (2020-03-01) -
Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics
by: P. Hemachandra Reddy
Published: (2011-02-01) -
Mitochondrial Antioxidants, Protection Against Oxidative Stress, and the Role of Mitochondria in the Production of Reactive Oxygen Species
by: Rogers, Kara Emilie
Published: (2006) -
Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review
by: Chisato Fujimoto, et al.
Published: (2019-04-01)